The Long Learning Curve For Artificially Intelligent Drug Manufacturing Begins Now

 
• By Bowman Cox

Drugmakers quickly adopt low-impact AI/ML models in quest to eventually automate manufacturing processes. Already, they are learning a lot about how these models can support their operations. One finding: innovative change management approaches may be required to unlock their full potential.

Big machine learning curve
the human learning curve comes first • Source: Shutterstock

More from Manufacturing Focus

More from In Vivo